Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Special Series: Advances in GI Cancer.

Literature DB >> 25918284

Special Series: Advances in GI Cancer.

Jeffrey A Meyerhardt¹, Joel E Tepper², Alan P Venook³.

Abstract

Entities: Disease

Mesh：

Year: 2015 PMID： 25918284 PMCID： PMC6815999 DOI： 10.1200/JCO.2015.60.8661

Source DB: PubMed Journal: J Clin Oncol ISSN： 0732-183X Impact factor: 44.544

× No keyword cloud information.

33 in total

1. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Authors: Yung-Jue Bang; Eric Van Cutsem; Andrea Feyereislova; Hyun C Chung; Lin Shen; Akira Sawaki; Florian Lordick; Atsushi Ohtsu; Yasushi Omuro; Taroh Satoh; Giuseppe Aprile; Evgeny Kulikov; Julie Hill; Michaela Lehle; Josef Rüschoff; Yoon-Koo Kang
Journal: Lancet Date: 2010-08-19 Impact factor: 79.321

2. Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303).

Authors: Hedy Lee Kindler; Donna Niedzwiecki; Donna Hollis; Susan Sutherland; Deborah Schrag; Herbert Hurwitz; Federico Innocenti; Mary Frances Mulcahy; Eileen O'Reilly; Timothy F Wozniak; Joel Picus; Pankaj Bhargava; Robert J Mayer; Richard L Schilsky; Richard M Goldberg
Journal: J Clin Oncol Date: 2010-07-06 Impact factor: 44.544

Review 3. Biliary tract cancers: understudied and poorly understood.

Authors: Emily Chan; Jordan Berlin
Journal: J Clin Oncol Date: 2015-04-27 Impact factor: 44.544

Review 4. Carcinoid and neuroendocrine tumors: building on success.

Authors: Pamela L Kunz
Journal: J Clin Oncol Date: 2015-04-27 Impact factor: 44.544

Review 5. Use of Imaging for GI Cancers.

Authors: Stuart Bentley-Hibbert; Lawrence Schwartz
Journal: J Clin Oncol Date: 2015-04-27 Impact factor: 44.544

Review 6. Metastatic colorectal cancer: current state and future directions.

Authors: Marwan G Fakih
Journal: J Clin Oncol Date: 2015-04-27 Impact factor: 44.544

Review 7. Personalizing colon cancer adjuvant therapy: selecting optimal treatments for individual patients.

Authors: Rodrigo Dienstmann; Ramon Salazar; Josep Tabernero
Journal: J Clin Oncol Date: 2015-04-27 Impact factor: 44.544

8. Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial.

Authors: Charles S Fuchs; Jiri Tomasek; Cho Jae Yong; Filip Dumitru; Rodolfo Passalacqua; Chanchal Goswami; Howard Safran; Lucas Vieira Dos Santos; Giuseppe Aprile; David R Ferry; Bohuslav Melichar; Mustapha Tehfe; Eldar Topuzov; John Raymond Zalcberg; Ian Chau; William Campbell; Choondal Sivanandan; Joanna Pikiel; Minori Koshiji; Yanzhi Hsu; Astra M Liepa; Ling Gao; Jonathan D Schwartz; Josep Tabernero
Journal: Lancet Date: 2013-10-03 Impact factor: 79.321